Answers are grounded in this paper and cite their sources.
Abstract Background Researches have shown that bile acids (BAs) is related to many tumors. However, the prognosis of intrahepatic cholangiocarcinoma (ICC) is poor. Therefore, this study explore biomarkers related to BAs metabolism and its regulatory mechanism in ICC. Methods TCGA-CHOL was downloaded from The Cancer Genome Atlas Program database. GSE107943, GSE26566, GSE32879 and GSE45001 were obtained from the Gene Expression Omnibus database. 57 bile acids metabolism-related genes (BARGs) were obtained. The candidate genes were obtained by difference analysis, KM survival analysis and machine learning. Next, independent prognostic factors were determined by univariate and multivariate analysis. Meanwhile, functional enrichment, immune infiltration and drug sensitivity analysis of biomarkers were performed, and the mechanism of biomarkers in ICC was explored. Finally, the expression levels of biomarkers were verified in different datasets. Results 40 differentially expressed BARGs (DE-BARGs) were obtained, among 18 genes were significantly associated with prognosis. CYP8B1, SCP2, SLC51A and SLCO1A2 were obtained as biomarkers, and SLCO1A2 was used as independent prognostic factor. Also, four biomarkers were correlated with Monocyte and Memory B cells, and seven immune cells were significantly associated with ICC prognosis. Besides, a ceRNA network was established, among SCP2 and SLCO1A2 were regulated through hsa-miR-543 and AC005261.1. Meanwhile, 61 drugs existed diversity between high and low expression groups of biomarkers. Finally, SCP2 and CYP8B1 were significantly expressed in the four data sets. Conclusion CYP8B1, SCP2, SLC51A and SLCO1A2 were identified as biomarkers related to BAs metabolism in ICC, which guided the clinical treatment of ICC patients.
No takes yet. Share an insight, caveat, or question.
Rong et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: